News German pricing rules hit Eisai's Halaven Drug has "no additional benefit" in metastatic liposarcoma, says IQWiG.
News Eisai angry over thyroid cancer drug impasse in England Thyroid cancer drug falls through gap in NHS funding
News Patients denied thyroid cancer drug in England Eisai considers legal action over funding "black hole".
News Isomorphic adds MSD to partner roster, and other deals It's been a busy dealmaking week, with Isomorphic Labs, fresh from a $5 billion financing, adding MSD to its list of research alliances.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.